- ISIN
- CA1380351009
- CUSIP
- 138035100
- Sector
- Healthcare
- IPO Date
- Apr 4, 2014
Highlights
- Market Cap
- $368.47M
- Enterprise Value
- $319.27M
- EPS (TTM)
- -CA$1.23
- Total Revenue (TTM)
- CA$312.34M
- Gross Profit (TTM)
- CA$77.66M
- EBITDA (TTM)
- -CA$205.34M
- Year Range
- $0.84 - $2.38
- Target Price
- $14.47
- ROA (TTM)
- -32.77%
- ROE (TTM)
- -52.56%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CGC Performance Chart
Canopy Growth Corporation (CGC) is down 16.0% since the beginning of the year. At $1 per share, CGC is trading 59.8% below its 52-week high of $2. Investors who bought $1,000 worth of CGC shares 5 years ago would now be looking at an investment worth $4.
Loading charts...
Returns By Period
Canopy Growth Corporation (CGC) has returned -16.04% so far this year and -22.81% over the past 12 months. Over the last ten years, CGC has returned -26.81% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Canopy Growth Corporation
- 1D
- -1.04%
- 1M
- -7.97%
- YTD
- -16.04%
- 6M
- -27.49%
- 1Y
- -22.81%
- 3Y*
- -43.03%
- 5Y*
- -66.76%
- 10Y*
- -26.81%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CGC Monthly Returns History
Based on dividend-adjusted daily data since Apr 7, 2014, CGC's average daily return is +0.07%, while the average monthly return is +1.26%. At this rate, an investment would double in approximately 4.6 years.
Historically, 39% of months were positive and 61% were negative. The best month was Mar 2024 with a return of +162.3%, while the worst month was Jun 2023 at -53.5%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 13 months.
On a daily basis, CGC closed higher 44% of trading days. The best single day was Sep 11, 2023 with a return of +81.4%, while the worst single day was Jul 14, 2023 at -40.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.39% | 2.75% | -15.25% | 16.94% | -1.80% | -12.19% | -16.04% | ||||||
| 2025 | -27.37% | -29.90% | -34.77% | 51.65% | -4.35% | -7.58% | -15.57% | 74.76% | -18.89% | -15.07% | -5.65% | -2.56% | -58.39% |
| 2024 | -8.61% | -29.55% | 162.31% | 72.42% | -42.67% | -24.38% | 17.83% | -31.45% | -7.49% | -4.77% | -15.69% | -29.20% | -46.38% |
| 2023 | 31.17% | -24.09% | -23.91% | -25.71% | -35.77% | -53.54% | 27.09% | 16.04% | 36.83% | -27.80% | -0.92% | -8.75% | -77.88% |
| 2022 | -7.90% | -11.44% | 6.46% | -24.67% | -12.96% | -42.66% | -7.72% | 39.92% | -25.82% | 36.63% | -2.95% | -36.19% | -73.54% |
| 2021 | 62.62% | -18.27% | -2.20% | -15.86% | -3.19% | -7.32% | -21.79% | -8.88% | -19.56% | -8.87% | -15.20% | -18.49% | -64.57% |
Benchmark Metrics
Canopy Growth Corporation has an annualized alpha of 0.85%, beta of 1.32, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since April 07, 2014.
- This stock participated in 162.81% of S&P 500 Index downside but only 7.02% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 0.85%
- Beta
- 1.32
- R²
- 0.06
- Upside Capture
- 7.02%
- Downside Capture
- 162.81%
Return for Risk
Risk / Return Rank
CGC ranks 34 for risk / return — below 34% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Canopy Growth Corporation (CGC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CGC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.25 | ||
| Sortino ratioReturn per unit of downside risk | -2.36 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.37 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.41 | 2.78 | -3.20 |
| Martin ratioReturn relative to average drawdown | -0.65 | 12.44 | -13.08 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Canopy Growth Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Canopy Growth Corporation was 99.85%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Canopy Growth Corporation drawdown is 99.83%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -99.85%Apr 2025 | 6y 5mo | — | 7y 8moOct 2018 - now |
2015 bear market2015 | -68.59%Sep 2015 | 1y 5mo | 1y 7d | 2y 6moApr 2014 - Oct 2016 |
2017 bear market2017 | -49.32%Jun 2017 | 6mo 22d | 4mo 1d | 10mo 23dNov 2016 - Oct 2017 |
2018 bear market2018 | -42.88%Feb 2018 | 26d | 4mo 15d | 5mo 11dJan 2018 - Jun 2018 |
2018 bear market2018 | -32.40%Jul 2018 | 28d | 1mo 1d | 1mo 29dJun 2018 - Aug 2018 |
Drawdown Indicators
| CGC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.85% | -56.78% | -43.07% |
Max Drawdown (1Y)Largest decline over 1 year | -55.38% | -9.10% | -46.28% |
Max Drawdown (3Y)Largest decline over 3 years | -95.10% | -18.90% | -76.20% |
Max Drawdown (5Y)Largest decline over 5 years | -99.67% | -25.43% | -74.24% |
Max Drawdown (10Y)Largest decline over 10 years | -99.85% | -33.92% | -65.93% |
Current DrawdownCurrent decline from peak | -99.83% | -1.80% | -98.03% |
Average DrawdownAverage peak-to-trough decline | -62.21% | -10.71% | -51.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.37% | 2.03% | +33.34% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Canopy Growth Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Canopy Growth Corporation is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CGC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CGC has a P/S ratio of 1.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CGC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, CGC has a P/B value of 0.7. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CGC
Add Canopy Growth Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CGC